Infinity Pharmaceuticals

Infinity lays off 78% of staff, 3 board members after MEI merger fails
Infinity lays off 78% of staff, 3 board members after MEI merger fails
Fierce Biotech
Infinity Pharmaceuticals
MEI Pharma
M&A
layoffs
Flag link:
Rebuffed by MEI Pharma, Infinity scuttles merger and may face bankruptcy
Rebuffed by MEI Pharma, Infinity scuttles merger and may face bankruptcy
Medical Marketing and Media
Infinity Pharmaceuticals
M&A
MEI Pharma
bankruptcy
Flag link:
The markets refuse to forgive Infinity
The markets refuse to forgive Infinity
EP Vantage
Infinity Pharmaceuticals
eganelisib
urothelial cancer
Flag link:
Unwanted by AbbVie and Infinity, battered Verastem gets an OK for duvelisib and a second shot at success
Unwanted by AbbVie and Infinity, battered Verastem gets an OK for duvelisib and a second shot at success
Endpoints
Verastem
AbbVie
Infinity Pharmaceuticals
duvelisib
Flag link:
Arcus Biosciences and Infinity Pharmaceuticals Partner to Evaluate Triple-Combination Therapy in Breast and Ovarian Cancer
Arcus Biosciences and Infinity Pharmaceuticals Partner to Evaluate Triple-Combination Therapy in Breast and Ovarian Cancer
CP Wire
Arcus Biosciences
Infinity Pharmaceuticals
drug development
IPI-549
AB928
AB122
breast cancer
ovarian cancer
Flag link:
Arcus Biosciences and Infinity Pharmaceuticals Partner to Evaluate Triple-Combination Therapy in Breast and Ovarian Cancer
Arcus Biosciences
Infinity Pharmaceuticals
breast cancer
ovarian cancer
Flag link:
On the ropes, Infinity gets a deal for duvelisib, with $0 up front as PI3k flounders
On the ropes, Infinity gets a deal for duvelisib, with $0 up front as PI3k flounders
Endpoints
duvelisib
Infinity Pharmaceuticals
Verastem
Flag link:
Here are 13 MA cancer biotechs hoping to make waves next month
Here are 13 MA cancer biotechs hoping to make waves next month
Bizjournals.com
Boston
biotech
ASCO 2016
Ariad Pharmaceuticals
Immunogen
Ziopharm
Vertex Pharmaceuticals
Tokai
Infinity Pharmaceuticals
Momenta
Merrimack
Tesaro
Syndax
Kyropharm
Foundation Medicine
Cerulean Pharma
Flag link:
Infinity Reports Phase 1 Data Showing Clinical Activity of Duvelisib in Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
Infinity Reports Phase 1 Data Showing Clinical Activity of Duvelisib in Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
Yahoo
Infinity Pharmaceuticals
ASCO
duvelisib
chronic lymphocytic leukemia
CLL
Flag link:
Infinity to Stop Development on Rheumatoid Arthritis Treatment
Infinity to Stop Development on Rheumatoid Arthritis Treatment
WSJ Online
Infinity Pharmaceuticals
rheumatoid arthritis
duvelisib
Flag link:
3 Partnerships Pushing The Pharmaceutical Sector Forward
3 Partnerships Pushing The Pharmaceutical Sector Forward
Yahoo/Benzinga
AbbVie
Infinity Pharmaceuticals
Clevexel Pharma
Guilin Pharmaceutical
The Chiesi Group
Pappas & Associates
Flag link:
Infinity Pharmaceuticals shares soar after AbbVie collaboration
Infinity Pharmaceuticals shares soar after AbbVie collaboration
Marketwatch
AbbVie
Infinity Pharmaceuticals
duvelisib
blood cancer
Flag link:
Infinity Pharma Snags Abbvie for Blood Cancer Drug Partnership
Infinity Pharma Snags Abbvie for Blood Cancer Drug Partnership
TheStreet.com
AbbVie
Infinity Pharmaceuticals
IPI-145
duvelisib
blood cancer
Flag link:
3 Small-Cap Biotechs That Institutions Are Loving
3 Small-Cap Biotechs That Institutions Are Loving
Yahoo/Benzinga
Infinity Pharmaceuticals
Vanda
Lexicon Pharmaceuticals
Flag link:
The Best- And Worst-Performing Biotech Stocks Of 2013
The Best- And Worst-Performing Biotech Stocks Of 2013
Forbes
biotech
Puma Biotechnology
Acadia
Isis Pharmaceuticals
Infinity Pharmaceuticals
Amarin
Ariad Pharmaceuticals
Aveo Oncology
Flag link:
4 Biggest Biotech Disasters Of 2013
4 Biggest Biotech Disasters Of 2013
Forbes
Amarin
Vascepa
Ariad Pharmaceuticals
Iclusig
Celsion
ThermoDox
IPI-145
Infinity Pharmaceuticals
Flag link:
Keep an Eye on These 3 Revolutionary Cancer Treatments in 2014
Keep an Eye on These 3 Revolutionary Cancer Treatments in 2014
Motley Fool
cancer
Roche
Infinity Pharmaceuticals
Inovio
Immunogen
Gilead Sciences
immunotherapy
antibody-drug conjugate
Flag link:
Infinity Reports Preclinical Data at ASH Annual Meeting in Diffuse Large B-Cell Lymphoma and T-Cell Acute Lymphoblastic Leukemia Suggesting Broad Potential of IPI-145 in Blood Cancers
Infinity Reports Preclinical Data at ASH Annual Meeting in Diffuse Large B-Cell Lymphoma and T-Cell Acute Lymphoblastic Leukemia Suggesting Broad Potential of IPI-145 in Blood Cancers
Yahoo/BusinessWire
large B-cell lymphoma
lymphoma
leukemia
T-cell acute lymphoblastic leukemia
IPI-145
Infinity Pharmaceuticals
Flag link:
[video]3 Blood Cancer Drug Hopefuls in the Spotlight
[video]3 Blood Cancer Drug Hopefuls in the Spotlight
Motley Fool
Infinity Pharmaceuticals
JNJ
Pharmacyclics
Gilead
non-Hodgkin's lymphoma
ibrutinib
Idelalisib
IPI-145
Flag link:
Infinity Pharmaceuticals And IPI-145: ASCO 2013 Highlights
Infinity Pharmaceuticals And IPI-145: ASCO 2013 Highlights
Seeking Alpha
ASCO
Infinity Pharmaceuticals
Gilead
IPI-145
Flag link:

Pages